Sustanon (testosterone) (DrugBank: Testosterone)
8 diseasesID | Disease name (Link within this page) | Number of trials |
---|---|---|
1 | Spinal and bulbar muscular atrophy | 0 |
2 | Amyotrophic lateral sclerosis | 0 |
3 | Spinal muscular atrophy | 0 |
13 | Multiple sclerosis/Neuromyelitis optica | 0 |
60 | Aplastic anemia | 0 |
78 | Hypopituitarism | 0 |
113 | Muscular dystrophy | 1 |
265 | Lipodystrophy | 0 |
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT02571205 (ClinicalTrials.gov) | November 2015 | 24/8/2015 | Testosterone Therapy for Pubertal Delay in Duchenne Muscular Dystrophy | Observational Study of Clinical Outcomes for Testosterone Treatment of Pubertal Delay in Duchenne Muscular Dystrophy | Duchenne Muscular Dystrophy | Drug: Sustanon (testosterone) | Newcastle-upon-Tyne Hospitals NHS Trust | NULL | Unknown status | 12 Years | 17 Years | Male | 15 | United Kingdom |